EWM
TXG icon

Evercore Wealth Management’s 10x Genomics TXG Stock Holding History

Evercore Wealth Management’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-12,282
Closed -$934K – 428
2022
Q1 		$934K Hold
12,282
– – 0.02% 229
2021
Q4 		$1.83M Hold
12,282
– – 0.03% 172
2021
Q3 		$1.79M Hold
12,282
– – 0.03% 174
2021
Q2 		$2.4M Buy
12,282
+4,382
+55% +$793K 0.04% 158
2021
Q1 		$1.43M Buy
7,900
+1,739
+28% +$300K 0.03% 191
2020
Q4 		$872K Buy
6,161
+1,960
+47% +$284K 0.02% 231
2020
Q3 		$524K Buy
+4,201
New +$441K 0.01% 257

Other funds holding TXG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Evercore Wealth Management's TXG Position: Q2 2022 in Review

Evercore Wealth Management sold out of 10x Genomics (TXG) in Q2 2022, closing a stake of 12,282 shares — an estimated $934K sold.

Evercore Wealth Management first reported a position in TXG in Q3 2020 and held it in 7 quarters. The position peaked at $2.4M in Q2 2021. 254 funds tracked by Wall St. Rank hold TXG as of Q2 2022.

  • Evercore Wealth Management reported no remaining 10x Genomics position as of Q2 2022 after selling out during the quarter.
  • Evercore Wealth Management sold 12,282 10x Genomics shares in Q2 2022, an estimated $934K.
  • Evercore Wealth Management first reported a position in 10x Genomics in Q3 2020 and held it in 7 quarters.
  • Evercore Wealth Management's 10x Genomics position peaked at $2.4M in Q2 2021.
  • 254 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2022.

Based on Evercore Wealth Management's 13F filing for Q2 2022, filed 15 Aug 2022.